OTC Advertisements In France To Carry COVID Warnings
French advertisements for OTC drugs that treat symptoms which could be associated with COVID-19 are set to carry new warning statements following a recommendation by the country's medicines regulator.
You may also be interested in...
Study of almost 10,000 COVID-19 patients finds use of ibuprofen and other NSAIDs does not increase chance of being hospitalized, admitted to the intensive care unit, or dying.
Dietary supplement ads should not make any explicit or implicit references to COVID-19, with immunity boosting claims also strictly off limits, says UK regulator the Advertising Standards Authority.
With around half the French population vitamin D deficient, a group of medical experts say mass supplementation is a low cost and low risk intervention which could save lives and curb the spread of COVID-19.